For: | Primignani M, Tosetti G, La Mura V. Therapeutic and clinical aspects of portal vein thrombosis in patients with cirrhosis. World J Hepatol 2015; 7(29): 2906-2912 [PMID: 26689354 DOI: 10.4254/wjh.v7.i29.2906] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v7/i29/2906.htm |
Number | Citing Articles |
1 |
Xizheng Zhu, Beijia Chen, Hui Xu. By modulating miR‐525‐5p/Bax axis, LINC00659 promotes vascular endothelial cell apoptosis. Immunity, Inflammation and Disease 2023; 11(1) doi: 10.1002/iid3.764
|
2 |
Qun Zhang, Renyong Guo, Yu Chen. D‐dimer level in liver transplant recipients on the first day after surgery is correlated with postoperative thrombosis recurrence. Journal of Clinical Laboratory Analysis 2019; 33(1) doi: 10.1002/jcla.22646
|
3 |
Jihyun Kwon, Youngil Koh, Su jong Yu, Jung-Hwan Yoon. Low-molecular-weight heparin treatment for portal vein thrombosis in liver cirrhosis: Efficacy and the risk of hemorrhagic complications. Thrombosis Research 2018; 163: 71 doi: 10.1016/j.thromres.2018.01.032
|
4 |
Alberto Zanetto, Krissia-Isabel Rodriguez-Kastro, Giacomo Germani, Alberto Ferrarese, Umberto Cillo, Patrizia Burra, Marco Senzolo. Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis. Transplant International 2018; 31(12): 1318 doi: 10.1111/tri.13353
|
5 |
Anita Rajasekhar, Marc Zumberg. Consultative Hemostasis and Thrombosis. 2019; : 300 doi: 10.1016/B978-0-323-46202-0.00017-0
|
6 |
MohamedSalem Al Saeed, BilalO Al-Jiffry, Alaa Younes, Samir Badr, Tamer Abdel-Rahman, Mohamed Hatem, Mahmoud El-Meteini. Risk factors, pattern of presentation, methods of diagnosis, and results of treatment of acute portal vein thrombosis: A multicenter study. Saudi Journal for Health Sciences 2019; 8(3): 182 doi: 10.4103/sjhs.sjhs_77_19
|
7 |
Meng Xu, Wanli Xue, Zhenhua Ma, Jigang Bai, Shengli Wu, Jerzy Kruk. Resveratrol Reduces the Incidence of Portal Vein System Thrombosis after Splenectomy in a Rat Fibrosis Model. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/7453849
|
8 |
Leona von Köckritz, Andrea De Gottardi, Jonel Trebicka, Michael Praktiknjo. Portal vein thrombosis in patients with cirrhosis. Gastroenterology Report 2017; 5(2): 148 doi: 10.1093/gastro/gox014
|
9 |
Arpit Taunk, Amar Mukund. Basics of Hepatobiliary Interventions. 2021; : 119 doi: 10.1007/978-981-15-6856-5_9
|
10 |
Hyeyoung Yang, Seo Ree Kim, Myeong Jun Song. Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban. Clinical and Molecular Hepatology 2016; 22(4): 499 doi: 10.3350/cmh.2016.0016
|
11 |
Andrea Mancuso. Portal Vein Thrombosis and Cirrhosis: The Role of Anticoagulation. Current Hepatology Reports 2017; 16(2): 158 doi: 10.1007/s11901-017-0344-z
|
12 |
F. Chegai, A. U. Cavallo, M. Forcina, V. Giuricin, F. Castellani, L. Greco, M. Manuelli, T. M. Manzia, G. Sergiacomi. Giant Splenorenal Shunt in a Young Patient with Autoimmune Hepatitis/Primary Biliary Cholangitis Overlap Syndrome and Portal Vein Thrombosis. Case Reports in Radiology 2017; 2017: 1 doi: 10.1155/2017/2167364
|
13 |
Gareema Tyagi, Roshan K Jha. Portal Vein Variations, Clinical Correlation, and Embryological Explanation: A Review Article. Cureus 2023; doi: 10.7759/cureus.36400
|
14 |
Zheng Guo Xu, Li Tang, Yong Bing Zhao, Ming Fa Gao, Shi Ming Yang. Catheter‐directed thrombolysis combined with anticoagulation for acute extensive portal vein thrombosis: Our experience. Journal of Digestive Diseases 2018; 19(10): 635 doi: 10.1111/1751-2980.12649
|
15 |
Dan Zheng, Jiao Yu, Hui Li, Hongying Gan, Jun Wang, Ting Jiang, Huanping Ren, Fan Wu. Effects of transjugular intrahepatic portosystemic shunt treatment of patients with liver cirrhosis and portal hypertension. Medicine 2021; 100(27): e26610 doi: 10.1097/MD.0000000000026610
|
16 |
Andrea Mancuso. Management of portal vein thrombosis in cirrhosis: an update. European Journal of Gastroenterology & Hepatology 2016; 28(7): 739 doi: 10.1097/MEG.0000000000000633
|